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Editorial
Quantifying and communicating peri-operative risk
Shallow men believe in luck.
Strong men believe in cause
and effect
—Ralph Waldo Emerson
Life is risky
Risk is the potential that a chosen
action or activity (including the
choice of inaction) will lead to a spe-
cific outcome, and implies that the
choice has an influence on the out-
come. Most definitions are synony-
mous with the possibility of an
adverse event but, of course, a risk
can also be taken in the hope of a
favourable outcome, particularly with
investment. There is also a personal
perspective on risk. A fatalist person-
ality may be very accepting and
unconcerned about risk whereas
more pragmatic individuals know
that there can be modifiable factors
involved. This can apply to health-
care; for example, even though sur-
gery may be necessary in a patient,
there may be pharmaceutical inter-
ventions that could reduce morbidity.
Almost any human endeavour carries
some risk. Staying in hospital is far
riskier than travelling by aeroplane. A
recent study showed that a one-night
stay in hospital carries a 11.1% risk of
nosocomial infection, a 3.4% risk of
an adverse drug reaction related to
human error or allergy, and a 0.4%
risk of pressure ulcer due to immobil-
isation [1]. In 2007 in the USA, there
were 1.31 fatal crashes per 100 000
flight hours for non-commercial
flights and 0.016 per 100 000 for
major airlines [2]. Despite efforts to
the contrary, healthcare is an intrinsi-
cally hazardous business.
Anaesthesia is a medical spe-
cialty very much focused on risk
management and patient safety and,
consequently, the mortality risk
attributable to anaesthesia itself has
dropped dramatically over the years,
from about one death in 1000
anaesthetic procedures in the 1940s
to one in 100 000 in the early 2000s
[3]. However, although anaesthesia
is relatively safe, surgery can be very
dangerous. In 2000, the 30-day mor-
tality risk in the UK was one death
in 34 emergency operations (2.9%)
and 1:177 after elective surgery
(0.6%) [4]. The European Surgical
Outcomes Study was an observa-
tional study in which data were col-
lected on 46 539 patients aged ≥
16 years undergoing non-cardiac
surgery, over a seven-day period, in
498 hospitals across 28 European
nations [5]. There was considerable
variability from country to country
but median death rates were 3% for
elective and 10% for emergency sur-
gery. Anaesthesia has an excellent
track record for patient safety and
has been described as the leading
medical specialty in addressing such
issues [6], yet it is apparent that the
peri-operative process still has great
potential for hazard from a host of
factors, of which anaesthesia is but
one.
Ronald A. Howard, a pioneer
of decision analysis, wanted to
develop a scale that would more
clearly confer risk rather than per-
centages. He coined the term
‘microprobability’ to refer to an
event with a chance of one in a
million. From this concept, a ‘micro-
mort’ (from ‘micro’ and ‘mortality’)
is then a one in a million chance of
death [7]. We face risk simply by
being alive and this may be exacer-
bated by indulging in various activi-
ties. A mobile app is now available
for illustrating how many micro-
morts are involved in our daily activ-
ities (see https://play.google.com/
store/apps/details?id=com.zanzibar-
tech.micromorts). The use of micro-
morts then allows us actually to
quantify risk and translate it into
whole numbers. A micromort
denotes a one in a million chance of
death from one-time dangerous
events, a concept that can be easily
understood and compared. A one in
a million chance is, of course, rare
but also an everyday occurrence. For
example, the chance of a particular
individual’s winning the weekly
lottery is less than 1 in 32 million
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people, but conversely this jackpot
gets won almost every week by
somebody. Micromorts are an
expression of acute risks, such that
once that event has been completed
the risk has gone. The risk of surgi-
cal anaesthesia is in the range of var-
ious day-to-day activities. Audits of
the risk of death from a general
anaesthetic alone vary considerably
geographically, but may be around
one death in 100 000 operations in a
developed country [8], which
equates to 10 micromorts per opera-
tion. This is the same risk of death,
on average, as riding a motorcycle
for 60 miles or skydiving. Micro-
morts rely on aggregated risk data
for calculations, so their applicability
to specific circumstances or individ-
uals is limited. In contrast with mi-
cromorts, there is also a unit called
microlife which is a risk (or gain)
representing a 30-minute change of
life expectancy [9]. It is a way of mea-
suring the impact of long-term hab-
its on the human body. For example,
smoking two cigarettes will ‘cost’ one
microlife; whereas bonus life can be
gained by taking a statin daily (one mi-
crolife per day) or doing 20 minutes of
moderate exercise daily (two microlives
per day). A user-friendly microlife cal-
culator (see http://journals.bmj.com/
site/microlives) is available. People in
general are notoriously bad at calculat-
ing risk. The concept of micromort and
microlife can be useful for explaining
various risks in our daily peri-operative
practice to the general public.
The blind leading the
blind?
Shared decision-making in the
healthcare context very often
depends on the understanding of
numerical information, in either text
or graphical format. The perception
of harm and benefit associated with
particular options is important for
many health decisions. Surprisingly,
not only patients but many doctors
have severe problems mastering a
host of numerical concepts that are
prerequisites for understanding
information about the harm and
benefit of medical treatments [10].
Highly educated people can still have
difficulty with relatively simple
numeracy questions [11]. Numeracy
influences the processing of both
numerical and non-numerical infor-
mation. Less numerate individuals
are more susceptible to framing
effects, more easily affected by non-
numerical information such as mood
states, and less sensitive to different
levels of numerical risk [12]. The
Berlin Numeracy Test is a new psy-
chometric instrument for assessing
statistical numeracy and risk literacy
in an educated population [13]. It
typically takes three minutes to com-
plete and an online version is now
also available (see http://www.risklit-
eracy.org).
Statisticians, clinicians and psy-
chologists have recommended the
use of numerical as opposed to ver-
bal descriptions for risk communica-
tion [14–16]. In addition to
probability information, the way
people perceive a risk message may
be influenced by the framing of risk
information, risk comparisons, the
message’s qualitative content and
trust [17]. Conveying relative risks
alone without absolute risk or base-
line risk is an example of non-trans-
parent framing. Comparing benefits
and harm using different scales, such
as reporting benefits in big numbers
by relative risk reduction and harm
in small numbers by absolute risk
increases, is another way of altering
risk perception. An example is the
1995 contraceptive pill scare in the
UK, where an alarming figure of a
100% increase (relative) in thrombo-
sis caused by third-generation oral
contraceptive pills was much more
terrifying than a humble increment
in absolute risk, from one in 7000 to
two in 7000 [18]. Humans can be
prone to unwittingly tricking them-
selves with representative bias in risk
assessment in gambling pursuits
such as purchasing lottery tickets. If
the odds of winning a lottery are one
in a million, then buying two tickets
will ‘double’ the chance to two in a
million (an apparent 100% increase).
However, the odds of not winning
the jackpot by buying two lottery
tickets hardly changes at all (from
99.9999% to 99.9998%; a change of
0.0001%).
Non-transparent and mis-
matched framings are common
phenomena, even for scientific
research published in leading medi-
cal journals. Studies have revealed
that up to half of articles report
only relative risks or odds ratios,
and about one third adopt mis-
matched framing for risk-benefit
discussion [19, 20]. Risk communi-
cation with incomplete and mis-
leading numerical descriptions
hinders shared decision-making.
Patients are likely to be familiar
with the concept of risk, but human
nature is such that many do not
understand the relativity or perhaps
even choose to ignore it. To use
gambling again as an example, a
recent $640 million lottery in the
USA created much excitement and
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a scramble to buy tickets when the
odds of winning were approxi-
mately one in 175 million. That
number may not mean much in
itself, but in relative terms the
chance of winning is 175 times less
than that of being struck by light-
ning in a given year, a fact that
helps conceptualise probability.
As in life, there is no zero risk
and no certainty in any branch of
medicine, but only risks that are
more or less acceptable. Communi-
cating risk information is important
but, unfortunately, more difficult
than might be expected. Patients’
values and preference are essential
elements of shared decision-making.
In 2011, a report on the peri-opera-
tive care of surgical patients pub-
lished by the National Confidential
Enquiry into Patient Outcome and
Death principally recommended
that “an assessment of mortality risk
should be made explicit to the
patient and recorded clearly on the
consent form and in the medical
record” [21]. A spreadsheet has
been developed to quantify mortal-
ity risk before and after surgery by
calculating mortality rates, and life
expectancy with adjustment for var-
ious parameters such as age, sex,
co-morbidities, renal function,
physical fitness, and body mass
index [22]. An on-line calculator is
available for estimating peri-opera-
tive mortality in order to assist
shared decision-making between
patients and their doctors when
non-surgical intervention is an
option (see https://sites.google.com/
site/informrisk/).
The complex nature of the
peri-operative period gives rise to
the potential for significant risk to
all patients. Directing efforts
towards patient safety can be
uncomplicated and inexpensive, yet
significantly improve the quality of
peri-operative care. The World
Health Organization’s surgical
safety checklist is an example of a
simple, cheap and effective method
of reducing avoidable complications
resulting from surgery [23]. More-
over, the use of a checklist is likely
to provide a net financial benefit to
the healthcare system because the
cost of the intervention is low
under all scenarios and there should
be a reduction in morbidity and
medicolegal claims. Anaesthesia is a
medical discipline of applied science
related to the art of peri-operative
risk reduction by identification,
intervention, and prevention.
To test or not to test
High-risk patients account for no
more than 15% of all surgical pro-
cedures but over 80% of deaths
[24]. However, it is still a major
challenge to identify accurately and
reliably patients who are at high
risk of postoperative mortality and
morbidity. Cardiopulmonary exer-
cise testing (CPET) is a measure of
aerobic capacity that is becoming
more widely employed, with the
estimated number of tests per-
formed in the UK alone estimated
to be in excess of 14 000 per year
[25]. Based on the possible associa-
tion of pre-operative aerobic fitness
with subsequent survival after
surgery, CPET has been used for
triaging patients with occult cardio-
respiratory disease for further
investigation and optimisation strat-
egies before major operations [26].
Nonetheless, none of the derived
variables, such as ventilatory anaer-
obic threshold or maximal oxygen
uptake, can be regarded as a cor-
nerstone for the prediction of sur-
vival after major surgery [27]. The
European Society of Cardiology’s
guidelines on pre-operative cardiac
risk assessment and peri-operative
cardiac management, published in
2009, questioned the role of CPET
in risk assessment before surgery
and emphasised that it is not a sub-
stitute for stress testing in routine
practice [28]. A scientific statement
from the American Heart Associa-
tion has also highlighted the lack of
randomised trials to support recom-
mendations for diagnostic and
prognostic applications of CPET
[29]. Reliance upon any single fac-
tor in predicting future risk is more
like gambling than rational assess-
ment, since no test is infallible. No
single variable can estimate the
extent of survival and quality of life,
although physical fitness appears to
be an important component [30,
31]. Pre-operative testing should
not be a screening exercise for sta-
ble patients but a strategic part of
the peri-operative risk reduction
programme for susceptible patients.
Risk assessment should always be
tailored to individual patients, and
pre-operative tests only reserved for
those in whom test results would
positively influence and change
peri-operative management. Our
drive to ‘optimise risk’ can lead to
unnecessary investigation and inter-
vention when we should really be
optimising ‘risk assessment’ through
more comprehensive history taking
and physical examination. Concerns
over malpractice liability result in
excessive and unnecessary consulta-
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tion, hospitalisation, testing, and
treatment can, paradoxically, be a
safety hazard for both patients and
doctors, with false positive findings
leading to costly and possibly harm-
ful treatments or further investiga-
tions and delays in surgery. The
quantity of tests should not be con-
fused with the quality of care.
Are drugs the answer?
Is there a pharmacological panacea
for peri-operative risk optimisation?
One of the main objectives of risk
identification is to determine which
individuals could benefit from a
protective, therapeutic intervention.
If that intervention is potentially
dangerous in itself, e.g. coronary
artery stenting, then careful selec-
tion is absolutely essential. There
are, however, fairly safe and simple
pharmacological treatments that are
very promising in this regard. It
may not be necessary to investigate
patients aggressively with expensive
and even hazardous techniques if
the indication for surgery is very
strong. Why not assume the worst
and instigate protective measures
anyway? Over the last decade, sta-
tins have been investigated exten-
sively for their potential multimodal
effects in modifying a number of
aspects of peri-operative morbidity
and mortality [32–34]. Possible
pleiotropic effects of statin therapy
are reduction of myocardial infarc-
tion and stroke, prevention of atrial
fibrillation, improvement of vascu-
lar draft survival, protection from
renal insufficiency, and inhibition
of malignant cell growth [34]. All
peri-operative applications of statins
are ‘off-label’, as their primary indi-
cation is lipid-lowering, but the
drugs, which are now available in
generic form, are relatively inexpen-
sive with a very good safety profile
[35]. However, in the latest Cochra-
ne review of statins for vascular
surgery, there was insufficient evi-
dence to conclude that use of sta-
tins resulted in either a reduction
or an increase in any of the out-
comes examined. It was also
observed that the widespread use of
statins in the population now will
make it difficult for researchers to
undertake the large randomised tri-
als needed to demonstrate any
effect [36].
Peri-operative pharmacological
interventions, while having certain
benefits, may themselves be associ-
ated with risk that could outweigh
such advantages. Data from the
POISE trial suggested that routine
administration of peri-operative
beta-blockers in an un-titrated, rela-
tively high dose starting on the day
of operation, increased the risk of
stroke and overall mortality for
non-cardiac surgery in the presence
of favourable outcomes on other
cardiovascular parameters [37, 38].
POISE II has generated similar con-
troversy recently over the use of
peri-operative aspirin [39].
Conclusions
Anaesthesia, as a service-based spe-
ciality dealing with specific inci-
dent-related risks, has not yet
reached its peak despite being
acknowledged as the leading medi-
cal speciality in designing fail-secure
systems and probably the only spe-
cialty in healthcare to have reached
the critical target of six sigma defect
rate [6, 40]. The peri-operative
period could be made safer by
revolutionising risk management
tactics with corresponding interven-
tions in preventing complications
and improving patient outcomes. It
has been suggested that the techni-
cal aspects of anaesthesia could be
delegated to robots [41], so are we
ready for our new role as peri-
operative risk strategists?
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